Phenylpyruvate

Phenylpyruvate

SCHEMBL468389

O=C(O)C(=O)Cc1ccccc1.[NaH]

nearest known ligand 0.95

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES1 P23141 3/20 0.76
CES2 O00748 2/20 0.76
FNTA P49354 2/20 0.61
FNTB P49356 2/20 0.61
AKR1B1 P15121 1/20 0.61
F2 P00734 2/20 0.55
CTBP2 P56545 1/20 0.54
PLG P00747 1/20 0.53
PRSS1 P07477 1/20 0.53
PRSS2 P07478 1/20 0.53
C1S P09871 1/20 0.53
PRSS3 P35030 1/20 0.53
MEN1 O00255 1/20 0.52
KMT2A Q03164 1/20 0.52
HDAC8 Q9BY41 1/20 0.52
HDAC6 Q9UBN7 1/20 0.52
CYP3A4 P08684 1/20 0.50
CYP2C9 P11712 1/20 0.50
ALDH1A1 P00352 1/20 0.48
MAPK1 P28482 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phenylpyruvate SCHEMBL11297524 0.98 CES1 (0.73) CES1CES2FNTAFNTBAKR1B1
Phenylpyruvate SCHEMBL43235 0.97 CES1 (0.80) CES1CES2FNTAFNTBAKR1B1
Phenylpyruvate SCHEMBL28203540 0.97 CES1 (0.80) CES1CES2FNTAFNTBAKR1B1
Phenylpyruvate SCHEMBL28232350 0.95 CES1 (0.76) CES1CES2FNTAFNTBAKR1B1
Phenylpyruvate SCHEMBL28233232 0.95 CES1 (0.76) CES1CES2FNTAFNTBAKR1B1
Phenylpyruvate SCHEMBL27281240 0.95 CES1 (0.76) CES1CES2FNTAFNTBAKR1B1
Phenylpyruvate SCHEMBL9217988 0.95 CES1 (0.76) CES1CES2FNTAFNTBAKR1B1
Phenylpyruvate SCHEMBL11193388 0.95 CES1 (0.76) CES1CES2FNTAFNTBAKR1B1
Phenylpyruvate SCHEMBL3408866 0.95 CES1 (0.76) CES1CES2FNTAFNTBAKR1B1
Phenylpyruvate SCHEMBL28233246 0.95 CES1 (0.76) CES1CES2FNTAFNTBAKR1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106366114-A 2-Oxo-3-phenylpropionic acid p-methylbenzoyl hydrazone dibenzyltin complex, and preparation method and application thereof 衡阳师范学院 2017-02-01 CN claimed
CN-106279261-A A kind of 2 carbonyl 3 phenylpropionic acids are to toluyl hydrazone di-n-butyl tin coordination compound and its preparation method and application 衡阳师范学院 2017-01-04 CN claimed
WO-2009018368-A1 COMBINATION TREATMENT OF NMDA (N-METHYL-D-ASPARTATE)-ENHANCER, GLYCINE TRANSPORTER INHIBITOR, D-AMINO ACID OXIDASE INHIBITOR (DAAOI) FOR NEUROPSYCHIATRIC DISORDERS LOS ANGELES BIOMEDICAL RESEARCH INSTITUTE AT HARBOR-UCLA MEDICAL CENTER (US) 2009-02-05 WO claimed
EP-4206322-A2 POLYPEPTIDE AND METHOD FOR PRODUCING AMINO ACID USING SAME CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2023-07-05 EP disclosed
US-11529342-B2 Sorbic and benzoic acid and derivatives thereof enhance the activity of a neuropharmaceutical LOS ANGELES BIOMEDICAL RESEARCH INSTITUTE AT HARBOR-UCLA MEDICAL CENTER (US) 2022-12-20 US disclosed
US-20220204918-A1 CELL CULTURE MEDIA COMPRISING KETO ACIDS MERCK PATENT GMBH (DE) 2022-06-30 US disclosed
CN-113461508-A Preparation method of alpha-ketophenylalanine calcium 北京福元医药股份有限公司沧州分公司 2021-10-01 CN disclosed
EP-3006023-B1 SORBIC ACID AND DERIVATIVES THEREOF TO ENHANCE THE ACTIVITY OF A NEUROPHARMACEUTICAL LOS ANGELES BIOMEDICAL RES INST HARBOR UCLA MEDICAL CT (US) 2019-06-26 EP disclosed
US-20190151301-A1 SORBIC AND BENZOIC ACID AND DERIVATIVES THEREOF ENHANCE THE ACTIVITY OF A NEUROPHARMACEUTICAL LOS ANGELES BIOMEDICAL RESEARCH INSTITUTE AT HARBOR-UCLA MEDICAL CENTER (US) 2019-05-23 US disclosed
EP-3006024-B1 BENZOIC ACID OR SALTS THEREOF TO ENHANCE THE ACTIVITY OF A NEUROPHARMACEUTICAL LOS ANGELES BIOMEDICAL RES INST HARBOR UCLA MEDICAL CT (US) 2019-03-20 EP disclosed
US-10149845-B2 Sorbic and benzoic acid and derivatives thereof enhance the activity of a neuropharmaceutical LOS ANGELES BIOMEDICAL RESEARCH INSTITUTE AT HARBOR-UCLA MEDICAL CENTER (US) 2018-12-11 US disclosed
CN-1049650-C Synthetic method of phenyl-pyruvic alkali salt and ammonium salt NANJING CHEMICAL ENGINEERING U (CN) 2000-02-23 CN disclosed
CN-1138022-A Synthetic method of phenyl-pyruvic alkali salt and ammonium salt NANJING CHEMICAL ENGINEERING U (CN) 1996-12-18 CN disclosed
EP-0395124-B1 Process for producing L-phenylalanine KYOWA HAKKO KOGYO KK (JP) 1994-06-01 EP disclosed
EP-0151488-B1 PROCESS FOR PRODUCING L-PHENYLALANINE KYOWA HAKKO KOGYO CO., LTD. (JP) 1991-09-25 EP disclosed
EP-0395124-A1 Process for producing L-phenylalanine KYOWA HAKKO KOGYO CO., LTD (JP) 1990-10-31 EP disclosed
US-4859591-A Transamination process for producing amino acids W. R. GRACE & CO.-CONN. (US) 1989-08-22 US disclosed
US-4783403-A FROM PHENYLPYRUVIC ACID AND AMINO GROUP DONOR USING MICRO-ORGANISM KYOWA HAKKO KOGYO CO., LTD. (JP) 1988-11-08 US disclosed
US-4584399-A ADSORBING IN ACTIVATED CARBON, ELUTING, PASSING THRU ION ECCHANGER W. R. GRACE & CO. (US) 1986-04-22 US disclosed
EP-0151488-A2 Process for producing L-phenylalanine KYOWA HAKKO KOGYO CO., LTD. (JP) 1985-08-14 EP disclosed